Stock LFST LIFESTANCE HEALTH GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News LifeStance Health Group, Inc.

Equities

LFST

US53228F1012

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-26 EDT 		5-day change 1st Jan Change
6.2 USD +0.65% Intraday chart for LifeStance Health Group, Inc. +8.58% -20.82%
03-12 LifeStance Health Appoints Teresa DeLuca to Its Board of Directors CI
03-06 Jefferies Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Buy Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
LifeStance to Host First Quarter 2024 Earnings Conference Call on May 9, 2024
GL
LifeStance Appoints Dr. Teresa DeLuca to Board of Directors
PR
LifeStance Health Appoints Teresa DeLuca to Its Board of Directors
CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
PR
Jefferies Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Buy Rating
MT
Lifestance Health Group Insider Sold Shares Worth $923,391, According to a Recent SEC Filing
MT
Goldman Sachs Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Neutral Rating
MT
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
PR
UBS Adjusts LifeStance Health Group Price Target to $9 From $7, Maintains Neutral Rating
MT
Barclays Adjusts LifeStance Health Group Price Target to $8 From $7, Maintains Underweight Rating
MT
Sector Update: Health Care Stocks Decline Late Afternoon
MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon
MT
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise
MT
LifeStance Health Q4 Loss Narrows as Revenue Increases; Shares Rise
MT
Transcript : LifeStance Health Group, Inc., Q4 2023 Earnings Call, Feb 28, 2024
LifeStance Health Group, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
LifeStance Health Group, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2024
CI
LifeStance Reports Fourth Quarter and Full Year 2023 Results
GL
LifeStance Health Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeStance Health Group, Inc. - LFST
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LFST Stock
  4. News LifeStance Health Group, Inc.